Lessons in PROTAC design from selective degradation with a promiscuous warhead

By Daniel P. Bondeson, Blake E. Smith, George M. Burslem, A. Buhimschi, J. Hines, S. Jaime-Figueroa, Jing Wang, B. Hamman, Alexey Ishchenko, C. Crews. Cell Chemical Biology, 2017

738 citations recorded by the source corpus.

Summary Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we report a previously understudied benefit of small molecule Proteolysis Targeting Chimera (PROTACs) that recruit E3 ubiquitin ligases to target proteins for their ubiquitination and subsequent proteasome-mediated degradation. Using promiscuous CRBN- and VHL-recruiting PROTACs that bind >100 kinases, we show that only a subset of bound targets is degraded. The basis of this selectivity relies on protein-protein interactions between the E3 ubiquitin ligase and the target protein, as illustrated by engaged proteins that are not degraded as a result of unstable ternary complexes with PROTAC-recruited E3 ligases. In contrast, weak PROTAC:target protein affinity can be stabilized by high affinity target:PROTAC:ligase trimer interactions, leading to efficient degradation. This study highlights design guidelines for generating potent PROTACs as well as possibilities for degrading undruggable proteins immune to traditional small molecule inhibitors.

Subfields: Electrical and Electronic Engineering, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/da278126df38a258e4f975532628937438ad88e5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. George M. Burslem
  2. M. Pettersson
  3. C. Crews

Citations in the corpus